| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.69e-07 | 14 | 74 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 4.86e-07 | 5 | 74 | 3 | GO:0086007 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved SA node cell action potential | 1.35e-05 | 2 | 74 | 2 | GO:0086059 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KATNAL2 FBH1 ATRX SHPRH ATP1A4 DNAH5 DNAH6 ATP4A DYNC1I1 ABCC10 DYNC1I2 | 1.53e-05 | 614 | 74 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.52e-05 | 46 | 74 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in AV node cell action potential | 4.05e-05 | 3 | 74 | 2 | GO:0086056 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.70e-05 | 118 | 74 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.32e-04 | 70 | 74 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | DNA translocase activity | 1.35e-04 | 5 | 74 | 2 | GO:0015616 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.24e-04 | 441 | 74 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 5.98e-04 | 10 | 74 | 2 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 5.98e-04 | 10 | 74 | 2 | GO:0005391 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 7.29e-04 | 11 | 74 | 2 | GO:0008556 | |
| GeneOntologyMolecularFunction | dynein light chain binding | 8.73e-04 | 12 | 74 | 2 | GO:0045503 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.35e-03 | 129 | 74 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | dynein heavy chain binding | 1.78e-03 | 17 | 74 | 2 | GO:0045504 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.99e-03 | 18 | 74 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 2.21e-03 | 775 | 74 | 9 | GO:0017111 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.40e-03 | 151 | 74 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.46e-03 | 152 | 74 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 3.75e-03 | 839 | 74 | 9 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 3.78e-03 | 840 | 74 | 9 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 3.78e-03 | 840 | 74 | 9 | GO:0016818 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 1.12e-05 | 142 | 73 | 6 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 1.12e-05 | 142 | 73 | 6 | GO:0098659 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 2.50e-05 | 48 | 73 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 2.50e-05 | 48 | 73 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 6.47e-05 | 61 | 73 | 4 | GO:0003254 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 6.90e-05 | 62 | 73 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 6.98e-05 | 121 | 73 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 7.16e-05 | 23 | 73 | 3 | GO:0086012 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 1.23e-04 | 5 | 73 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.23e-04 | 5 | 73 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.64e-04 | 230 | 73 | 6 | GO:0098739 | |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 1.84e-04 | 6 | 73 | 2 | GO:0086045 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 2.35e-04 | 34 | 73 | 3 | GO:0086019 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.57e-04 | 87 | 73 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.79e-04 | 36 | 73 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 3.32e-04 | 93 | 73 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | calcium ion import | 4.06e-04 | 98 | 73 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 4.12e-04 | 41 | 73 | 3 | GO:0086091 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 5.46e-04 | 10 | 73 | 2 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 5.46e-04 | 10 | 73 | 2 | GO:0086015 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.11e-05 | 46 | 74 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | microtubule associated complex | 2.29e-05 | 161 | 74 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 2.30e-05 | 47 | 74 | 4 | GO:0031462 | |
| GeneOntologyCellularComponent | dynein complex | 4.00e-05 | 54 | 74 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 9.26e-05 | 25 | 74 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.31e-04 | 73 | 74 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 7.97e-04 | 12 | 74 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | outer dynein arm | 7.97e-04 | 12 | 74 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 9.34e-04 | 212 | 74 | 5 | GO:0031461 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.58e-03 | 141 | 74 | 4 | GO:0048786 | |
| Domain | VDCCAlpha1 | 4.19e-08 | 10 | 72 | 4 | IPR002077 | |
| Domain | CAC1F_C | 5.49e-08 | 3 | 72 | 3 | IPR031688 | |
| Domain | CAC1F_C | 5.49e-08 | 3 | 72 | 3 | PF16885 | |
| Domain | VDCC_L_a1su | 2.19e-07 | 4 | 72 | 3 | IPR005446 | |
| Domain | VDCC_a1su_IQ | 1.90e-06 | 7 | 72 | 3 | IPR014873 | |
| Domain | GPHH | 1.90e-06 | 7 | 72 | 3 | PF16905 | |
| Domain | GPHH_dom | 1.90e-06 | 7 | 72 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 1.90e-06 | 7 | 72 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 1.90e-06 | 7 | 72 | 3 | PF08763 | |
| Domain | DYNC1I1/DYNC1I2 | 1.47e-05 | 2 | 72 | 2 | IPR025956 | |
| Domain | Dynein_IC2 | 1.47e-05 | 2 | 72 | 2 | PF11540 | |
| Domain | Channel_four-helix_dom | 6.87e-05 | 57 | 72 | 4 | IPR027359 | |
| Domain | - | 6.87e-05 | 57 | 72 | 4 | 1.20.120.350 | |
| Domain | P-type_ATPase_IIC | 2.18e-04 | 6 | 72 | 2 | IPR005775 | |
| Domain | APC_su10/DOC_dom | 3.04e-04 | 7 | 72 | 2 | IPR004939 | |
| Domain | DOC | 3.04e-04 | 7 | 72 | 2 | PS51284 | |
| Domain | SWIM | 3.04e-04 | 7 | 72 | 2 | PF04434 | |
| Domain | APC10 | 3.04e-04 | 7 | 72 | 2 | SM01337 | |
| Domain | ANAPC10 | 3.04e-04 | 7 | 72 | 2 | PF03256 | |
| Domain | Znf_SWIM | 5.18e-04 | 9 | 72 | 2 | IPR007527 | |
| Domain | ZF_SWIM | 5.18e-04 | 9 | 72 | 2 | PS50966 | |
| Domain | Ion_trans_dom | 9.84e-04 | 114 | 72 | 4 | IPR005821 | |
| Domain | Ion_trans | 9.84e-04 | 114 | 72 | 4 | PF00520 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.29e-03 | 14 | 72 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.29e-03 | 14 | 72 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.29e-03 | 14 | 72 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.29e-03 | 14 | 72 | 2 | PF08393 | |
| Domain | MT | 1.29e-03 | 14 | 72 | 2 | PF12777 | |
| Domain | AAA_8 | 1.29e-03 | 14 | 72 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.29e-03 | 14 | 72 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.29e-03 | 14 | 72 | 2 | PF07728 | |
| Domain | DHC_fam | 1.49e-03 | 15 | 72 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.49e-03 | 15 | 72 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.49e-03 | 15 | 72 | 2 | PF03028 | |
| Domain | - | 1.70e-03 | 16 | 72 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 1.70e-03 | 16 | 72 | 2 | IPR023298 | |
| Domain | PH | 1.90e-03 | 229 | 72 | 5 | PF00169 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.92e-03 | 17 | 72 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.92e-03 | 17 | 72 | 2 | PF00689 | |
| Domain | ZZ | 2.15e-03 | 18 | 72 | 2 | PF00569 | |
| Domain | Cation_ATPase_N | 2.15e-03 | 18 | 72 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 2.15e-03 | 18 | 72 | 2 | SM00831 | |
| Domain | ZF_ZZ_2 | 2.15e-03 | 18 | 72 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.15e-03 | 18 | 72 | 2 | PS01357 | |
| Domain | - | 2.21e-03 | 746 | 72 | 9 | 3.40.50.300 | |
| Domain | AAA+_ATPase | 2.32e-03 | 144 | 72 | 4 | IPR003593 | |
| Domain | AAA | 2.32e-03 | 144 | 72 | 4 | SM00382 | |
| Domain | Znf_ZZ | 2.40e-03 | 19 | 72 | 2 | IPR000433 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.40e-03 | 19 | 72 | 2 | IPR004014 | |
| Domain | ZnF_ZZ | 2.40e-03 | 19 | 72 | 2 | SM00291 | |
| Domain | - | 2.82e-03 | 73 | 72 | 3 | 2.60.120.260 | |
| Domain | Spectrin | 3.52e-03 | 23 | 72 | 2 | PF00435 | |
| Domain | WD40_repeat | 3.99e-03 | 272 | 72 | 5 | IPR001680 | |
| Domain | PH | 4.38e-03 | 278 | 72 | 5 | SM00233 | |
| Domain | WD_REPEATS_1 | 4.38e-03 | 278 | 72 | 5 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.44e-03 | 279 | 72 | 5 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.44e-03 | 279 | 72 | 5 | PS50294 | |
| Domain | PH_DOMAIN | 4.44e-03 | 279 | 72 | 5 | PS50003 | |
| Domain | PH_domain | 4.51e-03 | 280 | 72 | 5 | IPR001849 | |
| Domain | HECT | 4.83e-03 | 27 | 72 | 2 | PF00632 | |
| Domain | HECTc | 4.83e-03 | 27 | 72 | 2 | SM00119 | |
| Domain | HECT_dom | 4.83e-03 | 27 | 72 | 2 | IPR000569 | |
| Domain | HECT | 4.83e-03 | 27 | 72 | 2 | PS50237 | |
| Domain | P-loop_NTPase | 5.15e-03 | 848 | 72 | 9 | IPR027417 | |
| Domain | CRAL-TRIO_dom | 5.19e-03 | 28 | 72 | 2 | IPR001251 | |
| Domain | Spectrin_repeat | 5.56e-03 | 29 | 72 | 2 | IPR002017 | |
| Domain | Galactose-bd-like | 5.73e-03 | 94 | 72 | 3 | IPR008979 | |
| Domain | PH_dom-like | 5.98e-03 | 426 | 72 | 6 | IPR011993 | |
| Domain | SNF2_N | 6.75e-03 | 32 | 72 | 2 | IPR000330 | |
| Domain | Spectrin/alpha-actinin | 6.75e-03 | 32 | 72 | 2 | IPR018159 | |
| Domain | - | 6.75e-03 | 32 | 72 | 2 | 3.40.1110.10 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 7.84e-07 | 6 | 49 | 3 | M47762 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.09e-06 | 23 | 49 | 4 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.54e-06 | 25 | 49 | 4 | M47948 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 1.40e-05 | 14 | 49 | 3 | M47692 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.60e-05 | 63 | 49 | 4 | M11187 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 1.60e-04 | 79 | 49 | 4 | M17673 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.12e-04 | 42 | 49 | 3 | M7169 | |
| Pubmed | 7.33e-10 | 7 | 76 | 4 | 12900400 | ||
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 20937870 | ||
| Pubmed | 6.22e-08 | 47 | 76 | 5 | 8812413 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 4.33e-07 | 212 | 76 | 7 | 33853758 | |
| Pubmed | 5.57e-07 | 8 | 76 | 3 | 28330839 | ||
| Pubmed | 8.34e-07 | 9 | 76 | 3 | 16382099 | ||
| Pubmed | Transport of the outer dynein arm complex to cilia requires a cytoplasmic protein Lrrc6. | 8.34e-07 | 9 | 76 | 3 | 27353389 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.47e-06 | 38 | 76 | 4 | 30786075 | |
| Pubmed | 1.63e-06 | 11 | 76 | 3 | 18809727 | ||
| Pubmed | 4.48e-06 | 15 | 76 | 3 | 20188150 | ||
| Pubmed | 4.48e-06 | 15 | 76 | 3 | 24453333 | ||
| Pubmed | Cloning and characterization of two cytoplasmic dynein intermediate chain genes in mouse and human. | 4.71e-06 | 2 | 76 | 2 | 10049579 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20014384 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30001160 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21352396 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21054386 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 4.71e-06 | 2 | 76 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 4.71e-06 | 2 | 76 | 2 | 16267232 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 33144668 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24996399 | ||
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 4.71e-06 | 2 | 76 | 2 | 25966695 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24086669 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24849370 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 4.71e-06 | 2 | 76 | 2 | 26049024 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17015854 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 4.71e-06 | 2 | 76 | 2 | 16706838 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23761887 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 14981074 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 4.71e-06 | 2 | 76 | 2 | 25292336 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17526649 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 35130614 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12606379 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 4.71e-06 | 2 | 76 | 2 | 24941892 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24848473 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22826131 | ||
| Pubmed | C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. | 4.71e-06 | 2 | 76 | 2 | 16921373 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24470632 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24760982 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20657784 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 6.67e-06 | 17 | 76 | 3 | 27725084 | |
| Pubmed | Loss of the neurodevelopmental gene Zswim6 alters striatal morphology and motor regulation. | 9.47e-06 | 19 | 76 | 3 | 28433741 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 20226664 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 19351867 | ||
| Pubmed | Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth. | 1.41e-05 | 3 | 76 | 2 | 21832054 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 17289261 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24966091 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 21406960 | ||
| Pubmed | Potent inhibition of L-type Ca2+ currents by a Rad variant associated with congestive heart failure. | 1.41e-05 | 3 | 76 | 2 | 23973784 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 17767505 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 31302118 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 23045342 | ||
| Pubmed | Decreased cardiac L-type Ca²⁺ channel activity induces hypertrophy and heart failure in mice. | 1.41e-05 | 3 | 76 | 2 | 22133878 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 32555258 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 2173707 | ||
| Pubmed | Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. | 1.41e-05 | 3 | 76 | 2 | 24934288 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 31919478 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 26831068 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 38302612 | ||
| Pubmed | DNAH6 and Its Interactions with PCD Genes in Heterotaxy and Primary Ciliary Dyskinesia. | 1.41e-05 | 3 | 76 | 2 | 26918822 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 37739992 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 23338940 | ||
| Pubmed | Genetic dissection of horizontal cell inhibitory signaling in mice in complete darkness in vivo. | 1.41e-05 | 3 | 76 | 2 | 26024096 | |
| Pubmed | Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. | 2.82e-05 | 4 | 76 | 2 | 17110593 | |
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 2.82e-05 | 4 | 76 | 2 | 21788606 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 28247949 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 36383218 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 25015291 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 30250299 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 15451373 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 31663850 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 12060068 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 12897156 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 11296258 | ||
| Pubmed | 5.28e-05 | 604 | 76 | 8 | 38803224 | ||
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 7.03e-05 | 6 | 76 | 2 | 16029198 | |
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 3036582 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 9728334 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 21224388 | ||
| Pubmed | The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination. | 7.03e-05 | 6 | 76 | 2 | 27528230 | |
| Pubmed | Vimentin-dependent spatial translocation of an activated MAP kinase in injured nerve. | 7.03e-05 | 6 | 76 | 2 | 15748847 | |
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 23734214 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 12142566 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 11751894 | ||
| Pubmed | A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. | 9.83e-05 | 7 | 76 | 2 | 11163259 | |
| Pubmed | FBH1 CELSR3 ATRX TRIO SPTBN2 OSBPL8 HERC2 SIM2 TERF1 DYNC1I1 KPNA1 | 1.06e-04 | 1285 | 76 | 11 | 35914814 | |
| Pubmed | 1.13e-04 | 113 | 76 | 4 | 30352685 | ||
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 21737792 | ||
| Pubmed | Repurposing Brigatinib for the Treatment of Colorectal Cancer Based on Inhibition of ER-phagy. | 1.31e-04 | 8 | 76 | 2 | 31410188 | |
| Pubmed | Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33. | 1.31e-04 | 8 | 76 | 2 | 22451720 | |
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 17903303 | ||
| Pubmed | Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation. | 1.31e-04 | 8 | 76 | 2 | 33217317 | |
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 25231297 | ||
| Pubmed | HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus. | 1.31e-04 | 8 | 76 | 2 | 25818806 | |
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 1.31e-04 | 8 | 76 | 2 | 12761855 | |
| Pubmed | 1.65e-04 | 371 | 76 | 6 | 15747579 | ||
| Pubmed | Krox-20 is a key regulator of rhombomere-specific gene expression in the developing hindbrain. | 1.68e-04 | 9 | 76 | 2 | 9256343 | |
| Pubmed | 1.68e-04 | 9 | 76 | 2 | 15305290 | ||
| Pubmed | 2.10e-04 | 10 | 76 | 2 | 24778262 | ||
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 2.10e-04 | 10 | 76 | 2 | 18160036 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.45e-06 | 26 | 59 | 4 | 253 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 3.71e-04 | 9 | 59 | 2 | 90 | |
| GeneFamily | Dyneins, cytoplasmic | 7.98e-04 | 13 | 59 | 2 | 538 | |
| GeneFamily | Dyneins, axonemal | 1.38e-03 | 17 | 59 | 2 | 536 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.55e-03 | 18 | 59 | 2 | 91 | |
| GeneFamily | PRAME family | 2.76e-03 | 24 | 59 | 2 | 686 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.57e-03 | 206 | 59 | 4 | 682 | |
| GeneFamily | WD repeat domain containing | 1.05e-02 | 262 | 59 | 4 | 362 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-08 | 182 | 76 | 7 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | Control-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.62e-08 | 115 | 76 | 6 | cc2f8fb0cbb72b241b65a69195aac0507bddf2e2 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.17e-06 | 199 | 76 | 6 | c7d6a8398f2419b726a0461585d1ee0561654e3b | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.17e-06 | 199 | 76 | 6 | 85b3b1ad01368dae4adbc9da7efc148e49992f69 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-06 | 125 | 76 | 5 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | Control-B_activate-7|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.92e-06 | 130 | 76 | 5 | d3343c19d61928f18e7d707eda5dec6e0fd2a9a2 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.35e-06 | 165 | 76 | 5 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 172 | 76 | 5 | 1565f38266891c3acf49778838de134c5dee5460 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 184 | 76 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.58e-05 | 184 | 76 | 5 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 184 | 76 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 184 | 76 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 186 | 76 | 5 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 186 | 76 | 5 | 4dafc215c42e7949f932a3627359c107943b5d6b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 191 | 76 | 5 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-05 | 198 | 76 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, condition lineage and cell class | 2.30e-05 | 199 | 76 | 5 | a2be40d367338d32348a6906c8475aa3b544a0f7 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Deptor_(Deep_layer_pyramidal_cells--Layer_5a)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.53e-05 | 108 | 76 | 4 | 514dfc3f7ac303311ae599f981f3f3c7eb6801b8 | |
| Drug | Cinnarizine | 1.21e-08 | 9 | 73 | 4 | DB00568 | |
| Drug | Mibefradil | 3.15e-08 | 11 | 73 | 4 | DB01388 | |
| Drug | Verapamil | 1.72e-07 | 16 | 73 | 4 | DB00661 | |
| Drug | KW-3049 | 5.58e-07 | 50 | 73 | 5 | CID000002324 | |
| Drug | Nimodipine | 2.62e-06 | 9 | 73 | 3 | DB00393 | |
| Drug | (cis-) Nanophine [5072-45-7]; Up 200; 26.8uM; MCF7; HT_HG-U133A | 3.17e-06 | 196 | 73 | 7 | 3889_UP | |
| Drug | CNS 1145 | 3.71e-06 | 33 | 73 | 4 | CID000190902 | |
| Drug | IHC-64 | 3.71e-06 | 33 | 73 | 4 | CID000162753 | |
| Drug | nicardipine | 7.21e-06 | 145 | 73 | 6 | CID000004473 | |
| Drug | isotetrandrine | 1.51e-05 | 97 | 73 | 5 | CID000005422 | |
| Drug | prochloraz | 2.43e-05 | 268 | 73 | 7 | ctd:C045362 | |
| Drug | Podophyllotoxin [518-28-5]; Up 200; 9.6uM; PC3; HT_HG-U133A | 3.05e-05 | 187 | 73 | 6 | 5841_UP | |
| Drug | Cinildipine | 3.15e-05 | 56 | 73 | 4 | CID000002752 | |
| Drug | guanethidine | 3.16e-05 | 113 | 73 | 5 | CID000003518 | |
| Drug | AC1NBU2S | 3.74e-05 | 117 | 73 | 5 | CID004473765 | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 4.09e-05 | 197 | 73 | 6 | 6230_DN | |
| Drug | nilvadipine | 4.14e-05 | 60 | 73 | 4 | CID000004494 | |
| Drug | Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 4.21e-05 | 198 | 73 | 6 | 5886_UP | |
| Drug | IAA-94 | 4.42e-05 | 61 | 73 | 4 | CID000003667 | |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 4.45e-05 | 200 | 73 | 6 | 5454_UP | |
| Drug | lercanidipine | 5.02e-05 | 63 | 73 | 4 | CID000065866 | |
| Drug | Linuron | 5.74e-05 | 128 | 73 | 5 | ctd:D008044 | |
| Drug | enzacamene | 5.96e-05 | 129 | 73 | 5 | ctd:C038939 | |
| Drug | AC1L1TJF | 6.03e-05 | 66 | 73 | 4 | CID000003377 | |
| Drug | NSC-686960 | 6.06e-05 | 4 | 73 | 2 | CID000192816 | |
| Drug | sparfosic acid | 6.06e-05 | 4 | 73 | 2 | ctd:C013195 | |
| Drug | gallopamil | 6.40e-05 | 67 | 73 | 4 | CID000001234 | |
| Drug | AC1L2AC7 | 7.18e-05 | 69 | 73 | 4 | CID000068733 | |
| Drug | Barium | 8.48e-05 | 72 | 73 | 4 | ctd:D001464 | |
| Drug | octylmethoxycinnamate | 8.49e-05 | 139 | 73 | 5 | ctd:C118580 | |
| Drug | CAS 298-57-7 | 8.95e-05 | 73 | 73 | 4 | CID000002761 | |
| Drug | ethosuximide | 9.44e-05 | 74 | 73 | 4 | CID000003291 | |
| Drug | Nilvadipine | 1.01e-04 | 5 | 73 | 2 | DB06712 | |
| Drug | Nisoldipine | 1.01e-04 | 5 | 73 | 2 | DB00401 | |
| Drug | B 874-67 | 1.01e-04 | 5 | 73 | 2 | CID000195466 | |
| Drug | methyl beta-aminocrotonate | 1.01e-04 | 5 | 73 | 2 | CID000084253 | |
| Drug | nemadipine-A | 1.01e-04 | 5 | 73 | 2 | CID002856102 | |
| Drug | nimodipine | 1.04e-04 | 145 | 73 | 5 | CID000004497 | |
| Drug | nisoldipine | 1.16e-04 | 78 | 73 | 4 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.22e-04 | 79 | 73 | 4 | CID005287890 | |
| Drug | procaine | 1.33e-04 | 153 | 73 | 5 | CID000004914 | |
| Drug | butylparaben | 1.51e-04 | 157 | 73 | 5 | ctd:C038091 | |
| Drug | CPU-23 | 1.51e-04 | 6 | 73 | 2 | CID003036051 | |
| Drug | thiacloprid | 1.76e-04 | 34 | 73 | 3 | CID000115224 | |
| Drug | Amlodipine | 2.11e-04 | 7 | 73 | 2 | DB00381 | |
| Drug | Isradipine | 2.11e-04 | 7 | 73 | 2 | DB00270 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 5.80e-08 | 4 | 73 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.70e-06 | 35 | 73 | 4 | C0752122 | |
| Disease | Antihypertensive use measurement | 5.10e-05 | 265 | 73 | 6 | EFO_0009927 | |
| Disease | response to bevacizumab, Proteinuria | 6.01e-05 | 5 | 73 | 2 | EFO_0005943, HP_0000093 | |
| Disease | Spinocerebellar Ataxia Type 2 | 8.23e-05 | 34 | 73 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 8.23e-05 | 34 | 73 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 8.23e-05 | 34 | 73 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 8.23e-05 | 34 | 73 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 8.23e-05 | 34 | 73 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 8.23e-05 | 34 | 73 | 3 | C0087012 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 9.78e-05 | 36 | 73 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 1.26e-04 | 7 | 73 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 1.67e-04 | 8 | 73 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | Anemia, Sickle Cell | 2.68e-04 | 10 | 73 | 2 | C0002895 | |
| Disease | nervous system disease (implicated_via_orthology) | 3.92e-04 | 12 | 73 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 8.45e-04 | 447 | 73 | 6 | C3714756 | |
| Disease | selenium measurement, response to dietary selenium supplementation | 1.11e-03 | 20 | 73 | 2 | EFO_0006331, EFO_0600021 | |
| Disease | palmitoylcarnitine measurement | 1.23e-03 | 21 | 73 | 2 | EFO_0021044 | |
| Disease | cerebellar cortex volume measurement | 1.23e-03 | 21 | 73 | 2 | EFO_0010291 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.46e-03 | 335 | 73 | 5 | EFO_0009931 | |
| Disease | energy expenditure | 2.04e-03 | 27 | 73 | 2 | EFO_0005109 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLWLQLDCMSRGEDV | 11 | A0A0B4J249 | |
| WRLLAQEEAAMDAGA | 386 | Q8N6Y0 | |
| ALMAGCIQEARERWN | 36 | P38936 | |
| DWVRMGNALDNICFW | 446 | Q04844 | |
| QACADMWVDQARGLA | 461 | A6NK89 | |
| VMSSEGRALAQEWGC | 126 | Q9Y3L5 | |
| WASAIRVAALDCMEE | 111 | Q6ZRP7 | |
| GCGLDRLQWENVSAM | 121 | Q9Y530 | |
| AEANACWALEDLRCM | 841 | Q7RTW8 | |
| LFRCATGEAWQEIML | 1376 | O60840 | |
| MERLLAQLCGSSAAW | 1 | Q5T3U5 | |
| VNGCAADLSVCALWM | 71 | Q9GZN0 | |
| MRGLRCDGNADDIWT | 1206 | Q86YW9 | |
| WVLDDLCRNMDALSE | 11 | O43187 | |
| AFTRDGLCGLWNEMV | 26 | O95714 | |
| REMCNVVWRKLGDAA | 386 | A6NKD9 | |
| ALFACVDGMGRLDLW | 546 | O14576 | |
| ACVDGMGRLDLWNLN | 541 | Q13409 | |
| AMLVCAAWALALAAA | 141 | Q9NS67 | |
| VLAASNLPWELDCAM | 396 | Q8IYT4 | |
| FMEDRSAQAGNCWLR | 21 | P19883 | |
| MELAQEARELGCWAV | 1 | O94927 | |
| WVTGRAMELGRECLN | 431 | Q86U44 | |
| SDGRCWMDALELALK | 251 | Q9BZF1 | |
| DCRAILGVQEDNGMW | 286 | Q9P2J9 | |
| RLDSNALVCDCDLMW | 176 | A1KZ92 | |
| EELGWTAALGLDRMC | 316 | Q14376 | |
| TAALGLDRMCEDLWR | 321 | Q14376 | |
| MDEQCRWCAEGGNLI | 216 | P46100 | |
| WDIDLDNCVARMALS | 1416 | Q9C0G6 | |
| EASRLWDNMRKLGEC | 601 | Q8NFZ0 | |
| REVCQPAFDAIDMAW | 126 | Q66K79 | |
| LLFRCATGEAWQDIM | 1456 | Q13936 | |
| GDNWNGIMKDTLRDC | 1801 | O43497 | |
| MELQAARACFALLWG | 1 | P29317 | |
| MAARQIWARTGAALC | 1 | Q5VUE5 | |
| EKAFRAWGLEMNCDT | 721 | Q9UI17 | |
| FCVLNADARAAWMPA | 2771 | Q9NYQ7 | |
| DANVVCRQLGCGWAM | 1026 | Q9UGM3 | |
| LEDWCRGMDVNSQRA | 6 | Q8ND90 | |
| VWSEAMARGCFLNAK | 21 | H0Y7S4 | |
| QLAGGLQCLMWVAAA | 106 | P20648 | |
| RCATGEAWQEIMLAC | 1401 | Q01668 | |
| RANKGWALDNMVLCN | 4501 | Q8TE73 | |
| DWAQLDAGSMVLDVC | 426 | Q8IZ69 | |
| SQVLNMGAALAAWIC | 56 | A6NC51 | |
| NVCMAAVFVDRAGEW | 141 | Q96KG9 | |
| LAQDLCWELLASGMA | 181 | Q58EX7 | |
| WALGNIAGDSTMCRD | 191 | P52294 | |
| SWELSNLQGDRCIMG | 656 | Q96PQ0 | |
| WGQNEAADAMSRLAR | 671 | O14802 | |
| MDKLECGQLGNWRAS | 396 | Q14190 | |
| AAEMAQRLSGINRWC | 831 | Q149N8 | |
| WCIEAAARIREGMAA | 606 | P49748 | |
| WFMLARIAGLCNRAD | 426 | Q13733 | |
| VWLSAAMGFGNCVEL | 406 | Q6UXF7 | |
| WSEAMARGCFLNAKR | 116 | Q5VXH4 | |
| MTDKCRQLWDELGAL | 406 | Q9P217 | |
| CLRDLVAMQWADAAG | 426 | Q86XI8 | |
| LVFGRDAGMAEAWLC | 2016 | O15020 | |
| MTFENLAAWGRCLCA | 2926 | Q6ZS81 | |
| MPAIAVLAAAAAAWC | 1 | Q08629 | |
| DEQQYARWMAGCRLA | 441 | Q86UX7 | |
| EAVAAGWMLDFLCLS | 71 | P54274 | |
| EALWENMAVIDCFAS | 1671 | P27708 | |
| MAAASPLRDCQAWKD | 1 | Q5R3I4 | |
| VCLDSRVGLDWACSM | 2191 | O43149 | |
| APCWEEAMAAAFQLA | 131 | Q9BSN7 | |
| AGDGSSWRDDLCRLM | 1236 | Q6ZQQ6 | |
| AANSLDNLCRMDPAW | 3841 | Q9Y4A5 | |
| KCDMRENLWLNLTDG | 201 | P45974 | |
| ACLAQWHQGALDLMA | 466 | Q8IZ20 | |
| MADQGRLLDCVVRWG | 2871 | O75962 | |
| MTDKCRQLWDELGAL | 326 | Q9H7M6 | |
| RALCSLAIEGLWSMN | 481 | Q86W25 | |
| GWDEMKAGCDVRLDA | 3976 | P20929 | |
| LMCGLGDVDVNDWRQ | 851 | Q96PU5 |